Research

November 23, 2021

UAMS’ Analiz Rodriguez, M.D., Ph.D., Selected for Diversity in Clinical Trials Career Development Program

Yavonda Chase

UAMS neurosurgeon Analiz Rodriguez, M.D., Ph.D., is one of 52 early-stage researchers invited to participate in the Bristol Myers Squibb Foundation's Diversity in Clinical Trials Career Development Program.

LITTLE ROCK — The Bristol Myers Squibb Foundation (BMSF), along with its partners National Medical Fellowships and the American Association for Cancer Research, selected University of Arkansas for Medical Sciences (UAMS) neurosurgeon Analiz Rodriguez, M.D., Ph.D., to participate in its Diversity in Clinical Trials Career Development Program.

November 15, 2021

UAMS Receives $18.9 Million NIH Award to Address Health Disparities

David Robinson

Members of the research team include, (back row, l-r) Keneshia Bryant-Moore, Ph.D., FNP-BC, RN, Pebbles Fagan, Ph.D., Carol Cornell, Ph.D., Linda Luster and Christina Hamilton; (front) Elizabeth Taylor, Theresa Prewitt, Dr.P.H., and Tiffany Haynes, Ph.D. Pictured separately are, from top: Mark Williams, Ph.D., Chris Long, Ph.D., and Mignonne Guy, Ph.D. (Virginia Commonwealth University).

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received $18.9 million from the National Institutes of Health (NIH) to support new research and interventions that will focus on reducing cancer and cardiovascular disease disparities among people who live in rural areas and African American populations across Arkansas. The five-year award from…

November 12, 2021

UAMS Biostatistics Contributes to Groundbreaking ANCHOR Study

Marty Trieschmann

Jeanette Lee, Ph.D.

The UAMS Department of Biostatistics played a key role in a successful national clinical trial to treat anal cancer in persons living with HIV. Jeannette Y. Lee, Ph.D., UAMS biostatistics professor and biostatistics leader for the Winthrop P. Rockefeller Cancer Institute at UAMS, served as the statistical center director for the National Cancer Institute’s (NCI)…

October 28, 2021

UAMS Researchers See 12% Increase in Grant Funding for FY2021

David Robinson

As UAMS vice chancellor for Research and Innovation, Shuk-Mei Ho, Ph.D., oversees the institution's research enterprise.

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 12.2% this past year, with $177.4 million in grants by the end of the fiscal year on June 30. It is the second consecutive year with double-digit increases in research funding that comes from…

October 21, 2021

UAMS Participating in National Breast Cancer Screening Trial

Marty Trieschmann

Breast Center Director Gwendolyn Bryant-Smith, M.D., is leading the Cancer Institute's participation in a national mammography clinical trial.

The UAMS Winthrop P. Rockefeller Cancer Institute is participating in the National Cancer Institute’s TMIST (Tomosynthesis Mammographic Imaging Screening Trial). The study compares two standard breast cancer screening methods — tomosynthesis (3D) mammograms and digital (2D) mammograms — and is designed to help researchers determine whether one method is better than the other at finding…

October 11, 2021

UAMS Cancer Researcher Brian Koss, Ph.D., is First in State to Earn Prestigious NIH Director’s Award

Marty Trieschmann

Brian Koss, Ph.D., a researcher with the UAMS Winthrop P. Rockefeller Cancer Institute, is the state’s first recipient of the prestigious National Institutes of Health (NIH) Director’s Early Independence Award.

LITTLE ROCK — Brian Koss, Ph.D., a researcher with the UAMS Winthrop P. Rockefeller Cancer Institute, is the state’s first recipient of the prestigious National Institutes of Health (NIH) Director’s Early Independence Award.

August 25, 2021

NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study

Marty Trieschmann

Dr. Mayumi Nakagawa - With an additional $3.6 million from the National Institutes of Health, Mayumi Nakagawa's, M.D., Ph.D., ground-breaking HPV vaccine research tops $10 million.

Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).

August 19, 2021

UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana

David Robinson

Taren Swindle, Ph.D., here visiting a Head Start classroom in 2019, is leading the NCI-funded study that aims to improve diets in early care and education settings.

UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.

July 21, 2021

Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team

David Robinson

Members of the UAMS proteomics team are Alan Tackett, Ph.D. (center front), and (l-r) Stephanie Byrum, Ph.D., Rick Edmondson, Ph.D., Aaron Storey, Ph.D., and Samuel Mackintosh, Ph.D.

LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…

June 24, 2021

UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer

David Robinson

UAMS' Hui-Ming Chang, M.D., is leading the Phoenix Trial.

LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…


Next page